Solvay Pharma India (Delisted) block deals, bulk deals and stake changes

1. May 2010

   • AcquiredAbbott Capital India Ltd & PAC20.00% of the company10,09,942 sharesholds 88.85% after24 May 2010 · filed under the 1997 takeover rules · Open Offer

2. Apr 2010

   • AcquiredSantosh Tripathi7.88% of the company3,97,839 sharesholds 7.90% after16 Apr 2010 · filed under the 1997 takeover rules · Market

3. Feb 2010

   • AcquiredAbbott Holdings Luxemburg S.a.r.l. Dutch S.C.S PAC : Abbott Laboratories US68.85% of the company34,76,634 sharesholds 68.85% after15 Feb 2010 · filed under the 1997 takeover rules · IndirectAcquisition
   • AcquiredAbbott Holding Luxembourg S.a r.l. Dutch S.C.S. PAC : Abbott Laboratories, US68.85% of the company34,76,634 sharesholds 68.85% after15 Feb 2010 · filed under the 1997 takeover rules · IndirectAcquisition

4. Oct 2009

   • AcquiredBhavook Tripathi4,773 sharesholds 5.08% after23 Oct 2009 · filed under the 1997 takeover rules · Market
   • AcquiredBhavook Tripathi0.07% of the company3,728 sharesholds 5.03% after9 Oct 2009 · filed under the 1997 takeover rules · Market

5. Aug 2007

   • AcquiredBHAVOOK TRIPATHI0.14% of the company7,016 sharesholds 5.06% after29 Aug 2007

The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.